Tasso, a Seattle-based telemedicine company that specializes in remote, self-sampled blood collection, has raised $17 million in a series A round of funding. The telehealth market has boomed over the ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, today announced it received CE Mark certification for its Tasso+™ device, a ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the launch of its next generation technology for dried blood ...

Tasso has taken a major step forward in its plans to make quick, easy and widespread blood tests a reality, with an FDA clearance for its simple sample collection device. The Tasso+ lancet can be ...

Tasso has received $17 million in new funding to scale up production of its self-administered blood collection devices, designed to help enable telemedicine and diagnostic testing from the home. The ...

Partnership combines Tasso's clinical grade blood collection solutions and ARUP's gold standard testing capabilities to streamline and accelerate decentralized clinical research SEATTLE and SALT LAKE ...

Neurogen Biomarking has entered a collaboration to adopt Tasso’s needle-free blood collection technology into its at-home Alzheimer’s testing platform. The collaboration will see Neurogen's brain ...

Seattle startup Tasso closed a $17 million investment round to help grow its at-home blood collection platform. The company’s blood sample device, called Tasso OnDemand, lets people take their own ...

Designation expands the availability of Tasso’s patient-centric blood collection solution for decentralized clinical trials, home diagnostic testing, wellness and anti-doping uses to the European ...